J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views By: Benzinga via Benzinga July 10, 2014 at 16:31 PM EDT Johnson & Johnson's (NYSE: JNJ) pharmaceuticals products may drive second-quarter results to just above Street views when it ... Read More >> Related Stocks: Gilead Sciences Johnson & Johnson